Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of fingolimod treatment on microglial activation in multiple sclerosis
2014-000296-12Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of fingolimod in multiple sclerosis (MS), sponsored by Turku University Hospital. Primary endpoint: Change in microglial activation. Started Feb 2014; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2014-000296-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000296-12.